Q4 2016 Dimension Therapeutics Inc Earnings and Business Update Call

9/3/2017 8:30

Conference Call Dimension Therapeutics Inc

Dimension Therapeutics Inc Conference call or earnings call will be held on Mar 9, 2017
During the earnings conference call’s session, Dimension Therapeutics Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact Dimension Therapeutics Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
We are a leading gene therapy company focused on discovering and developing new therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations. The liver is a vital organ that plays an important role in human metabolism and key physiologic functions, and is the target organ for our initial programs: hemophilia B, hemophilia A, ornithine transcarbamylase, or OTC, deficiency, and glycogen storage disease type Ia, or GSDIa. We continue to advance our lead product candidate, DTX101, and, in January 2016, initiated dosing in our Pase I/II open-label clinical trial of DTX101 in adults with moderate/severe to severe hemophilia B.    
Read more Conference Call

Dimension Therapeutics Inc (DMTX)

840 Memorial Drive, Cambridge Massachusetts 02139, United States